kittredgeihuhyla1951.blogspot.com
million to settle a federal civil claim that a predecessotr company skirtedMedicaid requirements, the companyh and the said Thursday. The company said in a release that it admitted no wrongdoing through the The Justice Department had accused of underpayinhg drug rebates it was required to pay into Medicaid between 1995 and according to a separate Justice Departmentnews release. Aventisd Pharmaceuticals allegedly partnered with HMOs Kaiser Permanente Medical Care Program and an affiliate to repackagethe steroid-based anti-inflammatort nasal sprays Azmacort, Nasacort and Nasacort AQ.
In doinhg so, the Justice Department alleged, Aventia Pharmaceuticals did not accurately represenyt the price ofthe products, enabling it to avoid paying millionzs of dollars in rebates. Accordinfg to the Justice Department, $49 million of the settlemenr will be paid to the federal Morethan $40 million will be paid to though it was not immediately clea r which states would receive the money. The remaininvg $6 million will go to public health providers. Sanofi-aventids termed it an “opt-in” fund availablew to states wishing to settle claims similar to those of theJustice Department. Sanofi-aventis (NYSE: SNY) is base in Bridgewater, N.J.
According to the company’s Web the Kansas City facility “izs one of the company’s primaru manufacturing sites.” A company spokeswomanm couldn’t immediately be reached for comment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment